2013.8fda指南：anda：原料药和制剂稳定性试验问答中英文

《2013.8fda指南：anda：原料药和制剂稳定性试验问答中英文》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、201308FDA指南：ANDA：原料药和制剂稳定性试验问答（中英文）    GuidanceforIndustry 行业指南ANDAs:StabilityTestingofDrugSubstancesandProductsQuestionsandAnswersANDA：原料药和制剂稳定性试验问答DRAFTGUIDANCE指南草案Thisguidancedocumentisbeingdistributedforcommentpurposesonly.本指南文件发布仅供讨论。Commentsandsuggestionsregarding

2、thisdraftdocumentshouldbesubmittedwithin60daysofpublicationinthe FederalRegister ofthenoticeannouncingtheavailabilityofthedraftguidance.Submitelectroniccommentsto http://www.regulations.gov.SubmitwrittencommentstotheDivisionofDocketsManagement(HFA-305),FoodandDrugAdmini

3、stration,5630FishersLane,rm.1061,Rockville,MD20852.Allcommentsshouldbeidentifiedwiththedocketnumberlistedinthenoticeofavailabilitythatpublishesinthe FederalRegister.Forquestionsregardingthisdraftdocumentcontact(CDER)RadhikaRajagopalan240-276-8546.U.S. DepartmentofHealth

4、andHumanServicesFoodandDrugAdministrationCenterforDrugEvaluationandResearch(CDER)August2013GenericsGuidanceforIndustryANDAs:StabilityTestingofDrugSubstancesandProductsQuestionsandAnswersANDA：原料药和制剂稳定性试验问答Additionalcopiesareavailablefrom:OfficeofCommunicationsDivisionofD

5、rugInformation,WO51,Room2201CenterforDrugEvaluationandResearchFoodandDrugAdministration10903NewHampshireAve.,SilverSpring,MD20993Phone:301-796-3400;Fax:301-847-8714druginfo@fda.hhs.govhttp://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm

6、U.S. DepartmentofHealthandHumanServicesFoodandDrugAdministrationCenterforDrugEvaluationandResearch(CDER)August2013Generics ContainsNonbindingRecommendations Draft—NotforImplementationTABLEOFCONTENTSI.INTRODUCTION 介绍II.QUESTIONSANDANSWERS 问与答A.General 一般问题B.DrugMasterFil

7、e 药物主文件.C.DrugProductManufacturingandPackaging 药品生产和包装D.AmendmentstoPendingANDAApplication 未批准ANDA申请的增补E.StabilityStudies 稳定性试验.GuidanceforIndustry[1]ANDAs:StabilityTestingofDrugSubstancesandProductsQuestionsandAnswersANDA：原料药和制剂稳定性试验问答Thisdraftguidance,whenfinalized,wi

8、llrepresenttheFoodandDrugAdministration’s(FDA’s)currentthinkingonthistopic.Itdoesnotcreateorconferanyrightsfor